PubRank

J R Lurain

Author PubWeight™ 44.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. Int J Gynecol Cancer 2003 1.83
2 Laparoscopically assisted vaginal hysterectomy in a university hospital: report of 82 cases and comparison with abdominal and vaginal hysterectomy. Am J Obstet Gynecol 1993 1.78
3 Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996 1.76
4 Markedly elevated maternal serum alpha-fetoprotein associated with a normal fetus and choriocarcinoma of the placenta. Obstet Gynecol 1990 1.50
5 Uterine arteriovenous malformations: primary treatment with therapeutic embolization. J Vasc Interv Radiol 1991 1.27
6 Management of twin pregnancies consisting of a complete hydatidiform mole and normal fetus. Obstet Gynecol 1998 1.13
7 Natural history of hydatidiform mole after primary evacuation. Am J Obstet Gynecol 1983 1.13
8 Evaluating the total costs of chemotherapy-induced toxicity: results from a pilot study with ovarian cancer patients. Oncologist 2001 1.04
9 Ovarian carcinoma initially presenting as metastatic axillary lymphadenopathy. Gynecol Oncol 1997 1.03
10 Medroxyprogesterone acetate (Depo-Provera) vs. hydroxyprogesterone caproate (Delalutin) in women with metastatic endometrial adenocarcinoma. Cancer 1980 1.03
11 Familial ovarian cancer. Gynecol Oncol 1979 0.99
12 Gestational trophoblastic disease metastatic to the brain. Radiology 1996 0.98
13 Rare gynecologic malignancies. Curr Opin Obstet Gynecol 1991 0.98
14 Treatment of low-risk metastatic gestational trophoblastic tumors with single-agent chemotherapy. Am J Obstet Gynecol 1996 0.97
15 Repeat gestational trophoblastic disease. Obstet Gynecol 1984 0.97
16 Protein kinase C alpha expression is inversely related to ER status in endometrial carcinoma: possible role in AP-1-mediated proliferation of ER-negative endometrial cancer. Gynecol Oncol 2001 0.92
17 Endometrial adenocarcinoma metastatic to the scalp: case report and literature review. Gynecol Oncol 1997 0.90
18 Choriocarcinoma associated with term gestation. Am J Obstet Gynecol 1984 0.90
19 Flow cytometric evaluation of epithelial ovarian cancer. Am J Obstet Gynecol 1990 0.87
20 Oral contraceptive use and risk of gestational trophoblastic tumors. J Natl Cancer Inst 1999 0.87
21 Tumor size in endometrial cancer: a prognostic factor for lymph node metastasis. Obstet Gynecol 1987 0.86
22 Cystadenocarcinoma of the ovary in a 4-year-old: benign transformation during therapy. Cancer 1980 0.85
23 Tumor size in endometrial cancer. Cancer 1991 0.85
24 Invasive mole. Semin Oncol 1982 0.84
25 Fatal gestational trophoblastic disease: an analysis of treatment failures. Am J Obstet Gynecol 1982 0.84
26 Cytoplasmic localization of endothelial constitutive nitric oxide synthase in endometrial carcinomas. Tumour Biol 1997 0.83
27 Choriocarcinoma associated with ectopic pregnancy. Obstet Gynecol 1986 0.83
28 Hydatidiform mole: clinicopathologic associations with the development of postevacuation trophoblastic disease. Int J Gynaecol Obstet 1990 0.83
29 Gestational trophoblastic disease: treatment results at the Brewer Trophoblastic Disease Center. Obstet Gynecol 1982 0.82
30 The significance of positive peritoneal cytology in endometrial cancer. Gynecol Oncol 1992 0.82
31 Treatment of high-risk gestational trophoblastic disease with methotrexate, actinomycin D, and cyclophosphamide chemotherapy. Obstet Gynecol 1985 0.81
32 Perceptions of cisplatin-related toxicity among ovarian cancer patients and gynecologic oncologists. Gynecol Oncol 1998 0.81
33 Participation of the general gynecologist in surgical staging of endometrial cancer: analysis of cost and perioperative outcomes. Gynecol Oncol 2006 0.81
34 Fatal gestational choriocarcinoma. Clinicopathologic study of patients treated at a trophoblastic disease center. Cancer 1982 0.81
35 Ovarian tumor antigens. J Reprod Med 1983 0.80
36 Hsp70 and Hsc70 are preferentially expressed in differentiated epithelial cells in normal human endometrium and ectocervix. Cell Stress Chaperones 1997 0.79
37 Mutations of the estrogen receptor in endometrial carcinoma: evidence of an association with high tumor grade. Gynecol Oncol 1996 0.79
38 Castleman disease presenting as a pelvic mass. Obstet Gynecol 1996 0.79
39 Ectopic pregnancy causing hemothorax managed by thoracoscopy and actinomycin D. Obstet Gynecol 1998 0.78
40 Etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine for the treatment of metastatic, high-risk gestational trophoblastic disease. Obstet Gynecol 1992 0.78
41 Ovarian carcinoma metastatic to the choroid of the eye. Gynecol Oncol 1997 0.77
42 Late recurrences of vaginal clear cell adenocarcinoma. Gynecol Oncol 1996 0.77
43 The effect of reimbursement policies on the management of Medicare patients with refractory ovarian cancer. Semin Oncol 1999 0.77
44 Pregnancy outcome subsequent to consecutive hydatidiform moles. Am J Obstet Gynecol 1982 0.77
45 Unanticipated pregnancy with intrauterine growth retardation after radiation-induced ovarian failure. A case report. J Reprod Med 1996 0.76
46 Management of abnormal Papanicolaou smears in pregnancy. Obstet Gynecol 1979 0.76
47 Intrauterine device use and endometrial cancer risk. Int J Epidemiol 1997 0.76
48 The value of cervical cytology in HIV-infected women. Gynecol Oncol 1995 0.75
49 Dual-parameter flow cytometric analysis coupling the measurements of forward-angle light scatter and DNA content of archival ovarian carcinomas of low malignant potential. Anal Quant Cytol Histol 1991 0.75
50 Newer diagnostic approaches to the evaluation of gynecologic malignancies. Obstet Gynecol Surv 1982 0.75
51 Classification and staging of gestational trophoblastic tumors. Obstet Gynecol Clin North Am 1988 0.75
52 Flow cytometric evaluation of early invasive cervical cancer. Obstet Gynecol 1993 0.75
53 Gestational trophoblastic disease. The effect of duration of disease and hCG titer on response to therapy. J Reprod Med 1982 0.75
54 Leiomyoma causing massive ascites, right pleural effusion and respiratory distress. A case report. J Reprod Med 1997 0.75
55 Chylous ascites: a sequel of pelvic radiation therapy. Obstet Gynecol 1985 0.75
56 Microinvasive cervix cancer. Int J Gynaecol Obstet 1991 0.75
57 Cost analysis of second-line therapies for platinum-refractory ovarian cancer: reimbursement dilemmas for Medicare patients. Cancer Invest 1999 0.75
58 The role of contraception in the development of postmolar gestational trophoblastic tumor. Obstet Gynecol 1991 0.75
59 Laparoscopic descending colostomy in three patients with cervical carcinoma. Gynecol Oncol 1994 0.75
60 Metastatic gestational trophoblastic disease: secondary chemotherapy. N Y State J Med 1980 0.75
61 The study and treatment of gestational trophoblastic diseases at the Brewer Trophoblastic Disease Center, 1962-1979. Adv Exp Med Biol 1984 0.75
62 Colposcopic evaluation of DES-exposed progeny at two large medical centers: the squamous neoplasia problem. South Med J 1978 0.75
63 Placental site trophoblastic tumor associated with immature ovarian teratoma. Int J Gynaecol Obstet 1990 0.75
64 Hexamethylmelamine in ovarian cancer after failure of cisplatin-based multiple-agent chemotherapy. Gynecol Oncol 1987 0.75
65 DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases. Gynecol Oncol 1993 0.75
66 Endometrial adenocarcinoma associated with drug-induced hyperprolactinemia. Obstet Gynecol 1986 0.75
67 A two-step approach to the treatment of invasive vulvar cancer in pregnancy. Int J Gynaecol Obstet 1992 0.75
68 Major basic protein as a marker of malignant potential in trophoblastic neoplasia. Am J Obstet Gynecol 1996 0.75